Open AccessRecapping The Latest Vaccine Developments
Author(s) -
Atikaran Krishnamoorthy
Publication year - 2021
Publication title -
journal of undergraduate life sciences
Language(s) - English
Resource type - Journals
eISSN - 1911-8902
pISSN - 1911-8899
DOI - 10.33137/juls.v15i1.35982
Subject(s) - covid-19 , virology , social distance , contact tracing , china , medicine , political science , outbreak , infectious disease (medical specialty) , law , disease , pathology
Since the first case was identified in Wuhan, China in November 2019, there have been 84.5 million cases of COVID-19 and 1.8 million deaths from this virus globally as of January 5, 20211. To combat this virus’ spread, various strategies have been employed, such as mask mandates, social distancing, increased COVID-19 testing, and contact tracing. Since December 2020, another strategy has been made available: vaccines. This is because three vaccines that showed promising Phase 3 results are currently in use to help curb COVID-19.